Argitalpenak (177) JUAN CARLOS GARCIA MONCO CARRA argitalpenak

2024

  1. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 1, pp. 40-45

  2. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

2022

  1. A 57-year-old man with painful ophthalmoplegia and cavernous sinus involvement: Why this is not Tolosa–Hunt syndrome

    European Journal of Neurology, Vol. 29, Núm. 10, pp. 3127-3129

  2. Drip and ship and mothership models of mechanical thrombectomy result in similar outcomes in acute ischemic stroke of the anterior circulation

    Journal of Stroke and Cerebrovascular Diseases, Vol. 31, Núm. 10

  3. Optic neuropathy in a patient with COVID-19 infection

    Acta Neurologica Belgica

  4. Pearls & Oy-sters: Arteriovenous Malformation with Sinus Thrombosis and Thalamic Hemorrhage: Unusual Cause of Parkinsonism and Dementia

    Neurology, Vol. 98, Núm. 13, pp. 550-553

2021

  1. Bilateral facial nerve palsy associated with COVID-19 and Epstein–Barr virus co-infection

    European Journal of Neurology, Vol. 28, Núm. 1, pp. 358-360

  2. Chronic severe methanol intoxication after repeated mask cleansing due to fear of COVID-19: A new risk of coronaphobia

    European Journal of Neurology, Vol. 28, Núm. 10, pp. 3448-3451

  3. Epidemiology, pathophysiology, and classification of the neurological symptoms of post-COVID-19 syndrome

    Neurology Perspectives, Vol. 1, pp. S5-S15

  4. Neurologic Manifestations in a Prospective Unselected Series of Hospitalized Patients with COVID-19

    Neurology: Clinical Practice, Vol. 11, Núm. 2, pp. E64-E72

  5. Progressive Ataxia and Downbeat Nystagmus in an Adult

    JAMA Neurology

2020

  1. La afectación del sistema nervioso en Covid-19: manifestaciones clínicas y mecanismos fisiopatológicos

    Anales de la Real Academia Nacional de Medicina, Núm. 137, pp. 209-212

  2. Neurological reasons for consultation and hospitalization during the COVID-19 pandemic

    Neurological Sciences, Vol. 41, Núm. 11, pp. 3031-3038

  3. Non-convulsive status epilepticus in a patient with COVID-19 infection

    Clinical Neurophysiology

  4. Recurrent Vertebrobasilar Strokes Associated With Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)

    The neurologist, Vol. 25, Núm. 5, pp. 131-136

2019

  1. Akinetic mutism and status epilepticus due to Epstein Barr virus encephalitis

    Clinical Neurology and Neurosurgery, Vol. 185

  2. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: The REPOSE study

    Journal of Headache and Pain, Vol. 20, Núm. 1

  3. Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections

    Annals of Neurology, Vol. 85, Núm. 1, pp. 21-31

  4. Predictors of in-hospital mortality after ischemic stroke: A prospective, single-center study

    Health Science Reports, Vol. 2, Núm. 4